Quest Diagnostics (DGX) Tax Provisions (2009 - 2026)

Quest Diagnostics has disclosed Tax Provisions across 18 years of filings, most recently posting $74.0 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at $74.0 million, up 25.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $329.0 million (up 23.68% YoY), and the FY2025 annual result was $314.0 million, up 15.02% from the prior year.
• Tax Provisions came in at $74.0 million for Q1 2026 at Quest Diagnostics, down from $81.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $110.0 million in Q1 2022 to a low of -$4.0 million in Q4 2022.
• The 5-year median for Tax Provisions is $74.0 million (2024), against an average of $69.0 million.
• Across the five-year window, Tax Provisions plunged 103.51% in 2022 and soared 1100.0% in 2023, its largest moves.
• Quest Diagnostics' Tax Provisions stood at -$4.0 million in 2022, then jumped by 1100.0% to $40.0 million in 2023, then soared by 70.0% to $68.0 million in 2024, then grew by 19.12% to $81.0 million in 2025, then decreased by 8.64% to $74.0 million in 2026.
• The last three Tax Provisions figures came in at $74.0 million (Q1 2026), $81.0 million (Q4 2025), and $77.0 million (Q3 2025), per Business Quant data.